Molecular Medicine
A section of Biomolecules (ISSN 2218-273X).
Section Information
We invite you to submit your contributions focusing on but not restricted to:
- Molecular pathogenesis
- Molecular diagnosis
- Molecular basis of diseases
- Experimental therapeutic approaches based on novel pathomechanisms
- Gene and protein networks regulating pathogenetic processes
- Epigenetic mechanisms regulating pathogenesis of human diseases
- Cellular signaling mechanisms regulating pathogenetic processes
- Systems biology approaches of molecular pathogenesis
- Bioinformatics and translational aspects of approaches of molecular pathogenesis
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- PPARs as Key Regulators in Different Diseases (Deadline: 30 April 2024)
- Molecular Pathology of Amyotrophic Lateral Sclerosis (Deadline: 30 April 2024)
- Ion Channel Signaling in Cancer (Deadline: 30 April 2024)
- New Insights into Cardiovascular Immunology (Deadline: 30 April 2024)
- Pathogenesis and Potential Treatments of Neurointestinal Diseases (Deadline: 30 April 2024)
- Biomolecules in Development and Diseases of Urogenital System II (Deadline: 30 April 2024)
- Dysregulation of Calcium Signaling in Pathological Processes (Deadline: 30 April 2024)
- Lipids Metabolism in Cardiovascular Disease (Deadline: 30 April 2024)
- Targets and Treatment Approaches for End-Stage Liver Diseases (Deadline: 30 April 2024)
- Diabetic Retinopathy: From Pathophysiology to Therapeutic Perspectives (Deadline: 30 April 2024)
- The Role of Glial Cells in Neuroinflammation, Neurodegeneration, and Neuroimmunomodulation (Deadline: 30 April 2024)
- Inflammation and Hemostasis (Volume II) (Deadline: 30 April 2024)
- Vitamin D in Health and Disease—Honorary Special Issue Commemorating the Work of Dr. Luminita A. Stanciu (Deadline: 7 May 2024)
- Molecular Pathology, Diagnostics and Therapeutics of Retinal Diseases (Deadline: 15 May 2024)
- NAD Metabolism in Physiology and Pathology (Deadline: 15 May 2024)
- Zinc in Health and Disease Conditions II (Deadline: 25 May 2024)
- Targeting Neuroinflammation and Insulin Resistance for a Healthy Brain: Prevention and Treatment of Neurological and Psychiatric Disorders (Deadline: 31 May 2024)
- Advanced Nanotechnology for Health and Diseases (Deadline: 31 May 2024)
- Targeting Sodium Channels and Pumps for Cancer Therapy (Deadline: 31 May 2024)
- Neuroanatomy as an Implement for the Study of CNS Function and Dysfunction (Deadline: 31 May 2024)
- Molecular Advances in Inflammatory Bowel Disease (Deadline: 1 June 2024)
- Breast Cancer: Molecular Mechanisms and Targeted Therapies (Deadline: 20 June 2024)
- Inositol Phosphates in Health and Disease - Volume II (Deadline: 20 June 2024)
- Insights of Innate Immunology into Inflammation and Infections (Deadline: 30 June 2024)
- Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease II (Deadline: 30 June 2024)
- Epigenetics of Pulmonary Diseases (Deadline: 30 June 2024)
- The Role of Glia in Alzheimer's Disease (Deadline: 30 June 2024)
- Molecular Basis of Stress- and Trauma-Related Disorders (Deadline: 30 June 2024)
- Advances in Cancer Therapy Resistance (Deadline: 30 June 2024)
- Therapeutic Strategies via Skeletal and Mesenchymal Stem Cells in the Cranial and Dental Fields (Deadline: 30 June 2024)
- Eosinophils in Allergy and Related Diseases—Selected Papers from “The Workshop on Eosinophils in Allergy and Related Diseases 2022” (Deadline: 30 June 2024)
- Recent Advances in Neurological Diseases (Deadline: 30 June 2024)
- Fibrodysplasia Ossificans Progressiva (FOP): From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 June 2024)
- Epstein-Barr Virus Disease Mechanisms and Stress Responses II (Deadline: 30 June 2024)
- Signal Transduction to Transcription Factors in Health and Disease—Honorary Special Issue Commemorating the Work of Prof. Athanasios G. Papavassiliou (Deadline: 30 June 2024)
- Melatonin in Health and Disease (Deadline: 30 June 2024)
- New Insights into Cardiometabolic Diseases (Deadline: 30 June 2024)
- Vascular Disease and Thrombosis (Deadline: 30 June 2024)
- Learn from Machine Learning: The Identification of Biomarkers and Therapeutic Targets in Neurodegeneration (Deadline: 15 July 2024)
- PARPs in Cell Death and PARP Inhibitors in Cancers (Deadline: 20 July 2024)
- The Role of Oxidative Stress in Ovarian Cancer (Deadline: 31 July 2024)
- Neurocognitive Disorders: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 July 2024)
- Molecular Research in Uterine Physiology and Pathology (Deadline: 31 July 2024)
- Stress, Aging and Metabolism (Deadline: 31 July 2024)
- H2S, Polysulfides, and Enzymes: Physiological and Pathological Aspects 2.0 (Deadline: 31 July 2024)
- Advances in Cancer and Glycosylation (Deadline: 31 July 2024)
- The Role of Tumor Microenvironment in the Pathogenesis and Progression of Hematological Malignancies (Deadline: 31 July 2024)
- Esophageal Diseases: Molecular Basis and Therapeutic Approaches (Deadline: 31 July 2024)
- Molecular Mechanisms of Drug Resistance in Breast Cancer (Deadline: 1 August 2024)
- Tryptophan-Kynurenine Pathway in Health and Disease (Deadline: 20 August 2024)
- Advances in Melanoma Targeted Therapy (Deadline: 20 August 2024)
- Advances in the Molecular Mechanisms of Inflammatory Arthritis and Inflammation-Related Bone Changes (Deadline: 20 August 2024)
- The Role of Microglia in Aging and Neurodegenerative Disease (Deadline: 25 August 2024)
- Lymphangiogenesis in Health and Disease (Deadline: 10 September 2024)
- Placental-Related Disorders of Pregnancy II (Deadline: 15 September 2024)
- Tuberculosis: Immunopathogenesis and Therapeutic Strategies (Deadline: 15 September 2024)
- From the Past to the Present: Unveiling the Role of Biomolecules in Clinical History (Deadline: 15 September 2024)
- Tissue Calcification in Normal and Pathological Environments (Deadline: 20 September 2024)
- Gap Junctions and Connexins in Health and Disease - Volume II (Deadline: 20 September 2024)
- The Role of Arginine and Arginine Metabolites in Cerebro- and Cardiovascular Disease Targeted Therapy (Deadline: 25 September 2024)
- New Insights and Potential Therapeutic Options in Leukemia Metabolism Research (Deadline: 30 September 2024)
- Novel Insights into Autoimmune/Autoinflammatory Skin Diseases (Deadline: 30 September 2024)
- New Insights into Mechanisms and Therapeutics for Cardiovascular Disorders (Deadline: 30 September 2024)
- Rare Diseases: From Molecular Pathways to Therapeutic Strategies 2.0 (Deadline: 30 September 2024)
- Novel Insights on Cancer Stem Cells (Deadline: 30 September 2024)
- Role of Probiotics in Health and Disease (Deadline: 30 September 2024)
- Aptamer Therapeutics in Cancers: New Advances and Future Trends (Deadline: 30 September 2024)
- Redox Balance and Proteostasis Surveillance in Neurodegenerative Disorders (Deadline: 30 September 2024)
- Advanced Organometallic Syntheses for Biomedical Applications (Deadline: 30 September 2024)
- Novel Molecules for Cancer Treatment 2.0 (Deadline: 30 September 2024)
- Nutrition, Metabolism, and Obesity: Novel Strategies and Molecular Mechanisms—Future Perspectives (Deadline: 30 September 2024)
- Recent Trends in Kidney and Cardiovascular Diseases (Deadline: 30 September 2024)
- Molecular Advances in Rett Syndrome and Other Chromatin Related Disorders (Deadline: 1 October 2024)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 1 October 2024)
- Viral Respiratory Infection including COVID-19: From Molecular Mechanisms to Therapies Strategies (Deadline: 31 October 2024)
- Molecular Targets for Breast Cancer Therapy, 2nd Edition (Deadline: 31 October 2024)
- New Insights into Cancer Genomics (Deadline: 31 October 2024)
- Molecular Interventions in Ocular Disorders (Deadline: 31 October 2024)
- New Insights into Molecular Mechanisms and Therapeutics for Malaria (Deadline: 31 October 2024)
- Role of Iron Dysregulation in Chronic Inflammatory Diseases and Their Complications (Deadline: 20 November 2024)
- Intracerebral Hemorrhage: Advances in Preclinical Studies 2.0 (Deadline: 30 November 2024)
- State of the Art and Perspectives in Antimicrobial Peptides (Deadline: 30 November 2024)
- Immune Modulation and Atherosclerosis (Deadline: 30 November 2024)
- The Molecular and Pathophysiological Basis of Ectopic Fat Deposition in Non-adipose Tissues (Deadline: 30 November 2024)
- Molecular Mechanisms of Infectious Pathogen Adaptation, Emergence, and Re-emergence (Deadline: 30 November 2024)
- Biochemistry in Medicine—Honorary Special Issue Commemorating Research and Work of Professors Jan O. Aaseth and Jan Alexander (Deadline: 31 December 2024)
- Mitochondrial Medicine: A Themed Issue in Honor of Prof. Dr. Carl A. Pinkert (Deadline: 31 December 2024)
- State of the Art in Antiviral Therapy and Viral Diseases Diagnosis: An Update to 2022-2023 (Deadline: 31 December 2024)
- Molecular and Biochemical Mechanisms of Age-Related Macular Degeneration, Neuroophthalmological Diseases and Uveitis (Deadline: 31 December 2024)
- The Development of Translational Cancer Research: In Honor of a Pioneering Professor, Ulrik Ringborg (Deadline: 31 December 2024)
- The Role of CD36 in Human Health and Disease (Deadline: 31 January 2025)
- Diet and Immune Response (Deadline: 28 February 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Drug-Phototherapy (Closed)
- Emerging Targets and Tissue Engineering Strategies for Repair and Regeneration (Closed)
- Feature Papers in Section Molecular Medicine
- Metabolomics and Integrated Multi-Omics in Health and Disease
- Natural and Synthetic Compounds in Neurodegenerative Disorders (Closed)
- Recent Advances in Cancer Immunotherapy
- Recent Advances in Pancreatic Cancer (Closed)